Compare ESP & NYXH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ESP | NYXH |
|---|---|---|
| Founded | 1928 | 2009 |
| Country | United States | Belgium |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 165.6M | 161.9M |
| IPO Year | 1995 | 2021 |
| Metric | ESP | NYXH |
|---|---|---|
| Price | $63.74 | $1.59 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | ★ $64.00 | $9.33 |
| AVG Volume (30 Days) | 29.6K | ★ 111.0K |
| Earning Date | 05-13-2026 | 05-12-2026 |
| Dividend Yield | ★ 1.50% | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 2.74 | N/A |
| Revenue | ★ $43,950,872.00 | N/A |
| Revenue This Year | $10.30 | $213.98 |
| Revenue Next Year | $10.00 | $126.25 |
| P/E Ratio | $22.67 | ★ N/A |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $36.00 | $1.26 |
| 52 Week High | $74.77 | $6.87 |
| Indicator | ESP | NYXH |
|---|---|---|
| Relative Strength Index (RSI) | 57.68 | 52.13 |
| Support Level | $54.35 | $1.28 |
| Resistance Level | $67.31 | $1.70 |
| Average True Range (ATR) | 2.11 | 0.07 |
| MACD | 0.19 | 0.03 |
| Stochastic Oscillator | 64.52 | 75.95 |
Espey Manufacturing & Electronics Corp is a power electronics design and OEM manufacturing company delivering products for military and severe environment applications. Its products include power supplies, power converters, filters, power transformers, magnetic components, power distribution equipment, UPS systems, and antennas. The applications of these products include AC and DC locomotives, shipboard power, shipboard radar, airborne power, ground-based radar, and ground mobile power. Espey services include design and development to specification, build to specifications provided by the customer, build to print, design services, design studies, environmental testing services, metal fabrication, painting services, and development of automatic testing equipment.
Nyxoah SA is a health-technology company focused on the development and commercialization of solutions and services to treat sleep-disordered breathing conditions. The company's solution platform is based on the Genio system, a CE-Mark validated, user-centered, bilateral neurostimulation therapy to treat moderate to severe Obstructive Sleep Apnea (OSA), the common sleep disordered breathing condition that is associated with increased mortality risk and comorbidities including cardiovascular diseases, depression and stroke.